Blue Water Life Science Advisors, LP Care Dx, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $110 Million
- Q4 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 604,000 shares of CDNA stock, worth $11.3 Million. This represents 11.77% of its overall portfolio holdings.
Number of Shares
604,000
Previous 604,000
-0.0%
Holding current value
$11.3 Million
Previous $18.9 Million
31.42%
% of portfolio
11.77%
Previous 16.58%
Shares
9 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$98.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$90.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$49.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$45.1 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$41.3 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...